ID   OEE-III
AC   CVCL_A764
DR   cancercelllines; CVCL_A764
DR   Cosmic; 1590844
DR   Wikidata; Q54931869
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=22038905;
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Met918Thr (c.2753T>C); ClinVar=VCV000013919; Zygosity=Unspecified; Note=Somatic (CelloPub=CLPUB00412).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
RX   CelloPub=CLPUB00412;
RA   Siddiqui Z.G.;
RT   "Medullary thyroid cancer: the current state of tumour marker and
RT   treatment strategies.";
RL   Thesis MD (2015); Medical University of Graz; Graz; Austria.
//
RX   PubMed=12089864;
RA   Pfragner R., Wirnsberger G.H., Ingolic E., Niederle B.;
RT   "Medullary thyroid carcinomas in cell culture -- models for future
RT   therapies.";
RL   Wien. Klin. Wochenschr. 114:279-283(2002).
//
RX   PubMed=22038905; DOI=10.1002/ijc.26494;
RA   Flicker K., Ulz P., Hoger H., Zeitlhofer P., Haas O.A., Behmel A.,
RA   Buchinger W., Scheuba C., Niederle B., Pfragner R., Speicher M.R.;
RT   "High-resolution analysis of alterations in medullary thyroid
RT   carcinoma genomes.";
RL   Int. J. Cancer 131:E66-E73(2012).
//